Skip to content
★ Sign in to follow
AS

Alan S. Nies

Board Director
Director
Lexicon Pharmaceuticals, Inc.
Total declarations
12
Company
1
▲ Purchases (1 ops.)
€10k
▼ Sales (0 ops.)
—

Latest filing published 22 May 2023 for Lexicon Pharmaceuticals, INC..

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Alan S. Nies: trading record in brief

This profile gathers the share dealings of Alan S. Nies in Lexicon Pharmaceuticals, Inc., where the filings describe the role as board member. We count 12 filings; the first trade dates from 19 December 2007 and the latest from 21 May 2023.

Purchases make up the whole of the open-market record (1 purchase, €10k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 7 share grants and 4 option exercises.

The record was last updated on 22 May 2023 with an option exercise in Lexicon Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 6,899 days ago, on 20 December 2007. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Alan S. Nies

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations